The plant growth retardant Phosfon inhibits cholesterol formation by cell·free preparations of normal liver and the Morris hepatomas 5123C, 7794A, and 9618A. In addition, both Phosfon and Amo 1618 arc active in inhibiting cholesterol synthesis from acetate and mevalonate in slices of host liver and the hepatomas. Fatty acid synthesis from acetate was also reduced in the presence of the retardants.
I. INTRODUCTION
Inhibition of mammalian sterol biosynthesis is usually accomplished in two distinct ways. First, there are a group of chemicals which have been shown to affect at least one, and usually more than one, particular enzyme step in the biosynthetic sequence (Holmes and Bentz 1960; Holmes and Di Tullio 1962) . The second type of inhibition is produced in an, as yet, undefined manner by certain dietary factors such as high cholesterol diets, starvation, etc. (Sabine, Abraham, and Chaikoff 1967; Sabine, Abraham, and Morris 1968; Zuckerman et al. 1970) . Dietary factors are particularly effective in inhibiting cholesterol biosynthesis in normal livers, but appear to lack any control function in the regulation of cholesterol biosynthesis in either primary or transplanted hepatomas. The reason for the difference in sensitivity between normal and cancerous hepatic tissue is not clear.
Recently, several publications (Paleg 1970a (Paleg , 1970b have demonstrated that a group of structurally unrelated chemicals, collectively called "plant growth retardants", have thc capacity to inhibit cholesterol synthesis by cell-free preparations derived from normal rat livers. In common with the SK&F series of sterol synthesis inhibitors, several of the retardants possess a quaternary nitrogen; other members of the group, however, have phosphonium ions or other types of active configurations (Cathey 1964) .
Since the plant growth retardants produce agriculturally desirable crop responses, and since, also, they have been shown to inhibit mammalian cholesterol biosynthesis, it was decided to investigate further their effects on mammalian systems. The results of this work report the extension of retardant (Amo 1618 and Phosfon) effectiveness to whole-cell preparations in the form of liver slices, and the similarity in effect of the retardants on normal liver and three "minimal-deviation" hepatomas.
II. MATERIALS AND METHODS

(a) Animals and Diets
Adult male rats of the Buffalo strain were used, each carrying intramuscularly one of the Morris hepatomas-51230, 7794A, or 9618A. Our original supply of these hepatomas and our original breeding stock of Buffalo-strain rats were generously donated by Dr. H. P. Morris, formerly of the National Oancer Institute, Bethesda, Md., U.S.A. The tumor-bearing animals used in these studies either had been air-freighted from the United States some months prior to an experiment or were subsequent transplant generations produced in Adelaide. All animals received a standard laboratory diet (Oharlicks' M164 mouse cubes) and water ad libitum.
(b) Plant Growth Retardants
Phosfon (tributyl-2,4-dichlorobenzylphosphonium chloride) was a gift from the Mobil Ohemical Oompany, Ashland, Va., U.S.A., and Amo 1618 (2-isopropyl-4-dimethylamino-5-methylphenyl-1-piperidinecarboxylate methyl chloride) was purchased from Oalbiochem. These were dissolved in saline before addition to the incubations.
(c) Tissue Incubations
The standard procedures used for the preparation and incubation of tissue homogenates (Paleg 1970a (Paleg , 1970b and slices (Sabine, Abraham, and Ohaikoff 1967) and for the collection, isolation, and counting of 140-labelled cholesterol (as the digitonin precipitate) and long-chain fatty acids (Sabine, Abraham, and Ohaikoff 1967; Paleg 1970a Paleg , 1970b 
III. RESULTS
(a) Tissue Homogenates
The inhibiting effect of Phosfon on cholesterol synthesis from mevalonate is shown in Table 1 . The results demonstrate that cholesterol synthesis by homogenates of three different hepatomas can be inhibited by this retardant, and that the degree of inhibition was approximately the same for both host liver and hepatoma.
(b) Tissue Slices
In addition to their effects on tissue homogenates, Phosfon (Table 2) and Amo 1618 (Table 3) inhibit the conversion of [1-14C]acetate and [2-14 C]mevalonate to cholesterol and long-chain fatty acids by tissue slices. Cholesterol synthesis in both liver and hepatoma was reduced by the addition of retardant and, furthermore, the retardants (particularly Phosfon) reduced the incorporation of acetate into longchain fatty acids as well as into cholesterol. This is the first indication of an effect of these compounds in a mammalian system on a synthetic pathway other than that for cholesterol formation. A proportion of radioactivity from mevalonate appeared in the long-chain fatty acid fraction. As yet, we have no explanation for this, although Christophe and Popjack (1961) and Carroll (1964) have suggested that radioactivity in the "fattyacid fraction" after incubation with 14C-mevalonate may be in terpenoid acids, byproducts of the sterol biosynthesis pathway. No attempt has been made to identify the labelled compound(s) present,although we have found that mevalonate itself does not appear in this fraction. The data indicate, however, that incorporation of radioactivity from [14C]mevalonate into this fraction was not sensitive to the presence of the retardants. An important aspect of the potential effect of plant growth retardants on intact mammalian systems is their ability to affect whole cells. In this regard, the present results strongly suggest that plant growth retardants are potent sterol biosynthesis inhibitors when acting on intact cells, in the form of liver slices, as well as in cell-free liver preparations.
In common with the well-known sterol biosynthesis inhibitors, e.g. the SK&F compounds, the plant growth retardants inhibit at least one step between acetate and mevalonate and at least one step between mevalonate and cholesterol (Holmes and Di Tullio 1962; Paleg 1970a Paleg , 1970b . The precise step which is inhibited by each retardant, in each section of the biosynthetic sequence, has not been determined, although definitive evidence has been obtained, in as yet unpublished experiments, demonstrating that AnlO 1618 inhibits the cyclization of squalene-2,3-epoxide. It seems highly probable that Amo 1618 has the same effect in the cells of liver slices.
The nature of the lesion in the control of lipid metabolism in hepatomas is, as yet, unknown, although many recent papers (Sabine, Abraham, and Chaikoff 1967; Sabine, Abraham, and Morris 1968; Sabine 1969; Zuckerman et al. 1970) have clearly illustrated that cholesterol synthesis in both primary and transplanted hepatomas is not affected by factors that regulate it in normal liver. The present work indicates that' the two growth retardants, Phosfon and Amo 1618, not only affect cholesterol synthesis in three hepatomas as easily as they inhibit it in normal liver, but they also inhibit it to about the same extent in all four tissues. This suggests that the enzymic steps which are affected are the same in the normal rat liver and the hepatoma. Obviously, this brief investigation is not sufficient to negate the possibility that the biosynthetic sequence in liver and hepatoma is different. However, it does lend support to the suggestion that differential control of cholesterol synthesis in the liver and the cancerous tissue is vested in some other type of mechanism (Sabine 1969) , although much further work is needed with a range of sterol biosynthesis inhibitors to adequately determine differences in enzyme pathways or sensitivities between the normal and the cancerous tissue or both. Although it does not seem to have been used before, the technique of assessing with inhibitors the sterol biosynthetic pathway of hepatomas appears to offer certain advantages.
These findings emphasize the need for further research into the in vivo effect of plant growth retardants on mammalian systems, and suggest that these compounds may be useful in helping to elucidate the mechanisms controlling cholesterol synthesis.
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